| Literature DB >> 35268700 |
Piotr Paweł Wieczorek1, Nataliia Hudz2,3, Oksana Yezerska2, Vladimira Horčinová-Sedláčková4, Mariia Shanaida5, Oleksii Korytniuk6, Iza Jasicka-Misiak3.
Abstract
This review aims to analyze propolis as a potential raw material for the development and manufacture of new health-promoting products. Many scientific publications were retrieved from the Scopus, PubMed, and Google Scholar databases via searching the word "propolis". The different extraction procedures, key biologically active compounds, biological properties, and therapeutic potential of propolis were analyzed. It was concluded that propolis possesses a variety of biological properties because of a very complex chemical composition that mainly depends on the plant species visited by bees and species of bees. Numerous studies found versatile pharmacological activities of propolis: antimicrobial, antifungal, antiviral, antioxidant, anticancer, anti-inflammatory, immunomodulatory, etc. In this review, the composition and biological activities of propolis are presented from a point of view of the origin and standardization of propolis for the purpose of the development of new pharmaceutical products on its base. It was revealed that some types of propolis, especially European propolis, contain flavonoids and phenolic acids, which could be markers for the standardization and quality evaluation of propolis and its preparations. One more focus of this paper was the overview of microorganisms' sensitivity to propolis for further development of antimicrobial and antioxidant products for the treatment of various infectious diseases with an emphasis on the illnesses of the oral cavity. It was established that the antimicrobial activity of different types of propolis is quite significant, especially to Gram-negative bacteria and lipophilic viruses. The present study could be also of interest to the pharmaceutical industry as a review for the appropriate design of standardized propolis preparations such as mouthwashes, toothpastes, oral drops, sprays, creams, ointments, suppositories, tablets, and capsules, etc. Moreover, propolis could be regarded as a source for the isolation of biologically active substances. Furthermore, this review can facilitate partially overcoming the problem of the standardization of propolis preparations, which is a principal obstacle to the broader use of propolis in the pharmaceutical industry. Finally, this study could be of interest in the area of the food industry for the development of nutritionally well-balanced products. The results of this review indicate that propolis deserves to be better studied for its promising therapeutic effects from the point of view of the connection of its chemical composition with the locality of its collection, vegetation, appropriate extraction methods, and standardization.Entities:
Keywords: biological properties; botanical origin; chemical composition; health-promoting products; propolis
Mesh:
Substances:
Year: 2022 PMID: 35268700 PMCID: PMC8911684 DOI: 10.3390/molecules27051600
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The structures of some mono- and sesquiterpenoids.
Figure 2The structures of some diterpenoids.
Figure 3The structures of amyrins.
Figure 4The structures of some flavonoids identified in propolis.
The main biologically active compounds found in the different propolis samples.
| Group | Representatives | Propolis Type | Reference |
|---|---|---|---|
| Terpenoids | |||
| Mono- and sesquiterpenoids | Cedrol (17.0%) | Algerian, Oum El Bouaghi | [ |
| α-Pinene and β-pinene | Brazilian | [ | |
| Limonene | Venezuelan | [ | |
| β-Caryophyllene and nerolidol | Argentinian green | [ | |
| Cedrol, γ-eudesmol, phenethyl alcohol, benzyl alcohol, 2-3,4-dimethoxystyrene, methoxy-4-vinylphenol, and guaiol | Chinese | [ | |
| Diterpenes | Clerodane diterpenes | Brazilian | [ |
| Cembrene (C20H32) and totarol (C20H30O) | Saudi Arabia (Baha) | [ | |
| Triterpenoids | α-Amyrin | Ethiopian propolis | [ |
| Lupenone, α-amyrin and β-amyrin | Cameroonian | [ | |
| Fatty acids | |||
| Unsaturated fatty acids | Algerian | [ | |
| Saturated fatty acids | Oleic acid, nonanoic acid (C9H18O2), decanoic acid (C10H20O2), dodecanoic acid (C12H24O2) | Saudi Arabia | [ |
| Hexatriacontanoic acid (C36H72O2) | Cameroonian | [ | |
| Flavonoids | |||
| Flavanols | Catechin | Mexican | [ |
| Flavanones | Pinocembrin | Mexican | [ |
| European brown poplar | [ | ||
| Turkish (1.22 mg/g) | [ | ||
| Croatian (0–6.39 mg/mL) | [ | ||
| Irish, Czech, German | [ | ||
| Romanian poplar | [ | ||
| Polish | [ | ||
| Naringenin | Mexican | [ | |
| Pinostrobin | Turkish (2.93 mg/g) | [ | |
| Plathymenin | Nepalese | [ | |
| Flavanonols | Pinobanksin 3-acetate | Australian | [ |
| Pinobanksin-3- | European brown poplar | [ | |
| Pinobanksin | Turkish | [ | |
| Polish | [ | ||
| Flavones | Chrysin | Polish | [ |
| Mexican | [ | ||
| European brown poplar | [ | ||
| Turkish (2.94 mg/g) | [ | ||
| Croatian (0–8.02 mg/mL) | [ | ||
| Irish, Czech | [ | ||
| Romanian poplar | [ | ||
| Apigenin | Brazilian red | [ | |
| European brown poplar | [ | ||
| Croatian (0–1.23 mg/mL) | [ | ||
| Polish | [ | ||
| Luteolin | Turkish | [ | |
| Brazilian red | [ | ||
| Tectochrysyn | Croatian (0–16.07 mg/mL) | [ | |
| Apigenin-6,8-di- | Geopropolis from | [ | |
| Flavonols | Quercetin | Brazilian red | [ |
| Mexican | [ | ||
| European brown poplar | [ | ||
| Romanian poplar | [ | ||
| Polish | [ | ||
| Kaempferol | Mexican | [ | |
| European brown poplar | [ | ||
| Croatian (0–0.672 mg/mL) | [ | ||
| Polish | [ | ||
| Galangin | Polish | [ | |
| Turkish (0.09 mg/g) | [ | ||
| Croatian (0–8.71 mg/mL) | [ | ||
| Irish, Czech | [ | ||
| Romanian poplar | [ | ||
| Rutin | Turkish | [ | |
| Brazilian red | [ | ||
| Isoflavones | Homopterocarpin, medicarpin, | Brazilian red | [ |
| Medicarpin | Nepalese | [ | |
| Chalcons | 2′,3′,4′-Trimethoxychalcone, | Australian | [ |
| Phenolic acids | Caffeic acid | Turkish (0.17 mg/g) | [ |
| Algerian | [ | ||
| Polish | [ | ||
| Ferulic acid | Turkish (0.36 mg/g) | [ | |
| Croatian (0–1.370 mg/mL) | [ | ||
| Romanian poplar | [ | ||
| Polish | [ | ||
| Turkish (0.05–0.14 mg/g or 3.95 mg/g) | [ | ||
| Croatian (0–1.031 mg/mL) | [ | ||
| Romanian poplar | [ | ||
| Polish | [ | ||
| Algerian | [ | ||
| Turkish (0.07–0.24 mg/g) | [ | ||
| Chlorogenic acid | Algerian | [ | |
| Gallic acid | Algerian | [ | |
| Turkish (0.015–0.025 mg/g) | [ | ||
| Syringic acid | Turkish | [ | |
| Polish | [ | ||
| Vanilic acid | Polish | [ | |
| 3,5-Diprenyl-4-hydroxycinnamic acid, 3-prenyl-4-dihydrocinnamoloxy-cinnamic acid (C23H24O4) | Brazilian propolis | [ | |
Some pharmaceutical products tested in different studies.
| Product | Composition and Brief Technology | Activity | Reference |
|---|---|---|---|
| Toothpaste with propolis | There is no information in the paper | Reducing dental plaque formation | [ |
| Propolis extract (Spanish propolis) | The propolis extract was prepared under aseptic conditions; 20 g of unrefined propolis was crushed and dissolved in 100 mL of 66% ethanol. The mixture was kept at room temperature for 28 days and subsequently filtered | Antibacterial activity against anaerobic bacteria ( | [ |
| Nanoform of Turkish propolis | A total of 3.5 g of chitosan was dissolved in 230 mL of 2% aqueous acetic acid solution ( | Propolis-bearing polymeric | [ |
| Liposoms for subcutaneous administration | Liposoms contains a complex mixture which principally contains rutin, myricetin, quercetin, kaempferol, apigenin, pinocembrin, chrysin, and galanigin. Propolis was extracted with 95% ethanol three times, and the ethanol solution was retrieved. Then, the precipitation was extracted with ethyl acetate three times, and ethyl acetate was retrieved. At the end, the precipitation was dried in vacuum, and propolis flavonoids were obtained | Immunological enhancement activity | [ |
| Propolis apitherapeutic | There is no information in the paper | Propolis burn treatment led to enhanced collagens and its components expression | [ |
| Propolis granular (Yamada Apiculture Center, Inc., | Propolis granular was dissolved in 5% gum arabic, and propolis ethanol extract was dissolved in 1% ethanol | The relief of symptoms of allergic rhinitis through inhibition of histamine release | [ |
| Dried 13% solution of the aqueous extract of propolis | A 13% solution of the aqueous extract of propolis was supplied by Propharma (Stenlose, Denmark), which was prepared by aqueous decoction of crude propolis, collected from Denmark, China, Uruguay, and Brazil. This extract was standardized to contain not less than 0.05% of organic aromatic acids, chiefly caffeic, ferulic, isoferulic, cinnamic, and 3,4-dimethoxy-cinnamic acids in addition to trace amounts of various flavonoids. The aqueous extract was first concentrated, then spray-dried under high pressure before being incorporated into the milk formula. The sachets were intended to be given suspended in water as a milk drink orally once a day for two months. | Marked reduction in the incidence and severity of nocturnal attacks and improvement | [ |
| propolis-γ CD powder | The technology is not described | Anticancer | [ |
Figure 5The biological activities discussed in this paper.